Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513

Watchlist Manager
Chengdu Easton Biopharmaceuticals Co Ltd Logo
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Watchlist
Price: 30.69 CNY 0.39% Market Closed
Market Cap: 5.4B CNY
Have any thoughts about
Chengdu Easton Biopharmaceuticals Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Chengdu Easton Biopharmaceuticals Co Ltd

Current Assets 1.9B
Cash & Short-Term Investments 1.5B
Receivables 182.4m
Other Current Assets 191.1m
Non-Current Assets 1.5B
Long-Term Investments 81.1m
PP&E 1.3B
Intangibles 84.5m
Other Non-Current Assets 16m
Current Liabilities 661.1m
Accounts Payable 135.1m
Accrued Liabilities 63.5m
Short-Term Debt 227.2m
Other Current Liabilities 235.3m
Non-Current Liabilities 82.2m
Long-Term Debt 39.6m
Other Non-Current Liabilities 42.6m

Balance Sheet
Chengdu Easton Biopharmaceuticals Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
272
364
404
1 055
1 036
823
768
Cash
272
364
404
1 055
1 017
822
768
Cash Equivalents
0
0
0
0
19
1
0
Short-Term Investments
0
0
0
570
454
516
742
Total Receivables
57
105
153
170
149
192
182
Accounts Receivables
52
91
119
121
112
137
120
Other Receivables
5
15
34
48
37
55
62
Inventory
55
52
60
84
104
141
161
Other Current Assets
24
8
14
15
36
37
30
Total Current Assets
408
529
631
1 894
1 779
1 709
1 883
PP&E Net
163
217
310
588
921
1 170
1 282
PP&E Gross
163
217
310
588
921
1 170
1 282
Accumulated Depreciation
90
115
137
168
196
251
317
Intangible Assets
15
36
35
34
42
77
84
Long-Term Investments
2
3
3
3
3
49
81
Other Long-Term Assets
5
5
8
13
31
12
16
Total Assets
592
N/A
790
+33%
987
+25%
2 531
+156%
2 775
+10%
3 018
+9%
3 347
+11%
Liabilities
Accounts Payable
10
32
51
123
158
148
135
Accrued Liabilities
16
24
44
58
57
72
63
Short-Term Debt
0
1
10
42
70
117
227
Current Portion of Long-Term Debt
0
0
0
0
0
0
3
Other Current Liabilities
105
136
172
163
147
193
232
Total Current Liabilities
130
193
277
385
433
529
661
Long-Term Debt
0
0
0
0
0
0
40
Deferred Income Tax
0
0
0
0
0
1
1
Other Liabilities
17
15
13
50
51
43
41
Total Liabilities
147
N/A
208
+41%
290
+40%
436
+50%
484
+11%
573
+19%
743
+30%
Equity
Common Stock
90
90
90
120
120
120
120
Retained Earnings
134
269
356
531
728
880
1 041
Additional Paid In Capital
222
223
251
1 444
1 444
1 444
1 444
Treasury Stock
0
0
0
0
0
0
2
Total Equity
445
N/A
582
+31%
697
+20%
2 095
+200%
2 292
+9%
2 444
+7%
2 603
+7%
Total Liabilities & Equity
592
N/A
790
+33%
987
+25%
2 531
+156%
2 775
+10%
3 018
+9%
3 347
+11%
Shares Outstanding
Common Shares Outstanding
90
90
90
120
120
120
120

See Also

Discover More